Chemo-induced biology of PD-L1 and in vivo combination immune therapy for ovarian cancer

被引：0
|
作者：
Grabosch, Shannon
Zeng, Feitianzhi
Zhang, Lixin
Ma, Tianzhou
Tseng, George
Edwards, Robert P.
Vlad, Anda M.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-3208
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3208
引用
收藏
页数：4
相关论文
共 50 条
  • [1] PD-L1 antibody drug conjugate for cancer immune-chemo combination therapy
    Sau, Samaresh
    Petrovici, Alex
    Alsaab, Hashem
    Iyer, Arun K.
    CANCER RESEARCH, 2018, 78 (13)
  • [2] PD-L1 biology in response to chemotherapy in vitro and in vivo in ovarian cancer.
    Grabosch, Shannon
    Zeng, Feitianzhi
    Zhang, Lixin
    Strange, Mary
    Brozick, Joan
    Edwards, Robert P.
    Vlad, Anda
    CLINICAL CANCER RESEARCH, 2016, 22
  • [3] SIGNIFICANCE OF PD-1 AND PD-L1 EXPRESSION IN OVARIAN CANCER BIOLOGY
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Giridhar, S.
    Wenzel, S.
    Sprung, S.
    Lax, S.
    Zeimet, A.
    Fiegl, H.
    Marth, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 555 - 555
  • [4] SIGNIFICANCE OF PD-1 AND PD-L1 EXPRESSION IN OVARIAN CANCER BIOLOGY
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Giridhar, S.
    Wenzel, S.
    Sprung, S.
    Lax, S.
    Zeimet, A.
    Fiegl, H.
    Marth, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1714 - 1714
  • [5] Combination therapy with PD-1 or PD-L1 inhibitors for cancer
    Hayashi, Hidetoshi
    Nakagawa, Kazuhiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (05) : 818 - 830
  • [6] Combination therapy with PD-1 or PD-L1 inhibitors for cancer
    Hidetoshi Hayashi
    Kazuhiko Nakagawa
    International Journal of Clinical Oncology, 2020, 25 : 818 - 830
  • [7] A Combination of Glutaminase Inhibitor 968 and PD-L1 Blockade Boosts the Immune Response against Ovarian Cancer
    Wang, Jing-Jing
    Siu, Michelle Kwan-Yee
    Jiang, Yu-Xin
    Leung, Thomas Ho-Yin
    Chan, David Wai
    Wang, Huo-Gang
    Ngan, Hextan Yuen-Sheung
    Chan, Karen Kar-Loen
    BIOMOLECULES, 2021, 11 (12)
  • [8] PD-1/PD-L1 immune checkpoint blockade in ovarian cancer: Dilemmas and opportunities
    Peng, Zikun
    Li, Ming
    Li, Huayi
    Gao, Qinglei
    DRUG DISCOVERY TODAY, 2023, 28 (08)
  • [9] PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy
    Dermani, Fatemeh K.
    Samadi, Pouria
    Rahmani, Golebagh
    Kohlan, Alisa K.
    Najafi, Rezvan
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (02) : 1313 - 1325
  • [10] PD-1 and PD-L1 expression in ovarian cancer
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Reimer, D.
    Zeimet, A.
    Fiegl, H.
    Marth, C.
    ANNALS OF ONCOLOGY, 2016, 27
12345